Dana-Farber/Boston Children's Cancer and Blood Disorders Center

United States of America (USA)

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Dana-Farber/Boston Children's Cancer and Blood Disorders Center published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Dana-Farber/Boston Children's Cancer and Blood Disorders Center is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
16 1.30

Outputs by subject (Share)

Subject Count Share
Life Sciences 15 1.23
Chemistry 1 0.07

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 59.97% Domestic
  • 40.03% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by Share (100 total)

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, United States of America (USA)
  • Foreign institution
  1. University College London (UCL), United Kingdom (UK) (0.67)
    0.61
    0.06
  2. McGill University, Canada (0.62)
    0.03
    0.60
  3. University of Toronto (U of T), Canada (0.36)
    0.09
    0.27
  4. Medical University of Vienna (MUW), Austria (0.32)
    0.05
    0.26
  5. Helmholtz Association of German Research Centres, Germany (0.27)
    0.18
    0.09
  6. Novartis International AG, Switzerland (0.25)
    0.23
    0.02
  7. Heidelberg University (Uni Heidelberg), Germany (0.24)
    0.18
    0.06
  8. Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland (0.23)
    0.11
    0.12
  9. University of Turin (UNITO), Italy (0.21)
    0.11
    0.11
  10. Hopp Children's Tumor Center at NCT Heidelberg (KiTZ), Germany (0.20)
    0.17
    0.02

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs